Pedersen, R.S.; Thorlacius-Ussing, J.; Raimondo, M.G.; Langholm, L.L.; Schett, G.; Ramming, A.; Karsdal, M.; Willumsen, N.
Fibroblast Activation Protein (FAP)-Mediated Cleavage of Type III Collagen Reveals Serum Biomarker Potential in Non-Small Cell Lung Cancer and Spondyloarthritis. Biomedicines 2024, 12, 545.
https://doi.org/10.3390/biomedicines12030545
AMA Style
Pedersen RS, Thorlacius-Ussing J, Raimondo MG, Langholm LL, Schett G, Ramming A, Karsdal M, Willumsen N.
Fibroblast Activation Protein (FAP)-Mediated Cleavage of Type III Collagen Reveals Serum Biomarker Potential in Non-Small Cell Lung Cancer and Spondyloarthritis. Biomedicines. 2024; 12(3):545.
https://doi.org/10.3390/biomedicines12030545
Chicago/Turabian Style
Pedersen, Rasmus S., Jeppe Thorlacius-Ussing, Maria G. Raimondo, Lasse L. Langholm, Georg Schett, Andreas Ramming, Morten Karsdal, and Nicholas Willumsen.
2024. "Fibroblast Activation Protein (FAP)-Mediated Cleavage of Type III Collagen Reveals Serum Biomarker Potential in Non-Small Cell Lung Cancer and Spondyloarthritis" Biomedicines 12, no. 3: 545.
https://doi.org/10.3390/biomedicines12030545
APA Style
Pedersen, R. S., Thorlacius-Ussing, J., Raimondo, M. G., Langholm, L. L., Schett, G., Ramming, A., Karsdal, M., & Willumsen, N.
(2024). Fibroblast Activation Protein (FAP)-Mediated Cleavage of Type III Collagen Reveals Serum Biomarker Potential in Non-Small Cell Lung Cancer and Spondyloarthritis. Biomedicines, 12(3), 545.
https://doi.org/10.3390/biomedicines12030545
